Obesity Arrhythmias: Role of IL-6 Trans-Signaling
Source : https://pubmed.ncbi.nlm.nih.gov/39125976/
Obesity is a chronic disease that is rapidly increasing in prevalence and affects more than 600 million adults worldwide, and this figure is estimated to increase by at least double...
Obesity increases the risk of ventricular arrhythmias via IL-6 trans-signaling. Olamkicept, an IL-6 inhibitor, shows promise but its role in obesity-linked arrhythmias remains underexplored.
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Source : https://pubmed.ncbi.nlm.nih.gov/38264914/
The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these...
The 2024 AHA Statistical Update offers comprehensive global and local cardiovascular data, emphasizing health equity and addressing structural racism to improve outcomes and access to care for all populations.
Meal timing and its role in obesity and associated diseases
Source : https://pubmed.ncbi.nlm.nih.gov/38586455/
Meal timing emerges as a crucial factor influencing metabolic health that can be explained by the tight interaction between the endogenous circadian clock and metabolic homeostasis. Mistimed food intake, such...
Optimizing meal timing by aligning with circadian rhythms can enhance metabolic health and prevent obesity-related diseases. Future interventions should consider individual chronotype and external factors for effective lifestyle modifications.
Drug approach to treatment for obesity in adults: perspectives and considerations
Source : https://pubmed.ncbi.nlm.nih.gov/38345504/
Obesity is considered a chronic disease and a serious public-health issue in Spain, as well as in many other countries, primarily because of it being a significant risk factor for...
Obesity is a chronic disease and major public health issue in Spain, significantly increasing risk for multiple chronic conditions and cancers, with weight loss improving health outcomes.
Physiopathology and Treatment of Obesity and Overweight: A Proposal for a New Anorectic
Source : https://pubmed.ncbi.nlm.nih.gov/38566891/
The "new epidemic," as WHO calls obesity, is caused by overeating, which, having exceeded the body's actual needs, accumulates in the form of health-damaging fat deposits. Moving more and eating...
The article examines obesity, its causes, compulsive forms like food addiction, and explores pharmacological treatments, including a new anorectic, for managing compulsive obesity.
